News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Multicenter Analysis of High-Dose Chemotherapy Regimens For The Treatment of Patients With Refractory or Recurrent GCTs
Photo: Depositphotos
May 5, 2025, 13:03

Multicenter Analysis of High-Dose Chemotherapy Regimens For The Treatment of Patients With Refractory or Recurrent GCTs

ESMO Open shared a post on X:

“Multicenter analysis of high-dose chemotherapy regimens for the treatment of pts with refractory or recurrent GCTs in ESMO Open.
111 pts retrospectively analysed, similar results with CE vs TICE, potential benefit with TICE in higher risk disease.”

Title: Multicenter analysis of high-dose chemotherapy regimens for the treatment of patients with refractory or recurrent germ cell tumors

Authors: A. Chehrazi-Raffle, M. Zugman, H. Ebrahimi, M. O. Shodiya, E. Maldonado, T. Othman, S. Jaime-Casas, R. B. Carrillo, X. Li, S. K. Pal, A. Tripathi, A. Zhumkhawala, R. Hoeg, C. Oliai, R. L. Olin, T. B. Dorff, M. Mei

You can read the Full Article on ESMO Open.

Chemotherapy Regimens

More posts featuring ESMO Open.

cancer cancer treatment chemotherapy ESMO Open Germ Cell Tumors OncoDaily Oncology
Special Coverage
Blog
May 29, 2025, 19:20
Diego A. Díaz García: sq-NSCLC Data Shows Benmelstobart Plus Chemo as Promising New 1L Option
Positive
May 29, 2025, 19:09
Excited to Announce the 2025 Board of Directors - IASLC
Career
May 29, 2025, 19:02
Vincent Rajkumar: Thrilled Saad Usmani Will Receive the Giants of Cancer Care Award for Myeloma
Blog
May 29, 2025, 18:50
Narjust Florez: A Few Things I Wish I Knew as a Fellow While Starting the ASCO Journey
Science
May 29, 2025, 18:39
Melvin Chua: Progress in Focal Therapy for Prostate Cancer Can Be Made by Good Science
Blog
May 29, 2025, 18:26
Bench To Bedside on Drug Development for Rare and Economically Infeasible Cancers - FDA Oncology
Career
May 29, 2025, 18:16
The First 2025 Mentor of the Year Nominee: Mariana Chavez Mac Gregor - WinC - AlinC
Blog
May 29, 2025, 18:11
Manmeet Ahluwalia: Honored to Receive the Ellis Island Medal of Honor for Contributions to American Society
Positive
May 29, 2025, 17:58
Stephen Liu: Congratulations to the Newly Elected IASLC Board Members
Blog
May 29, 2025, 17:45
3D Printing in Radiation Oncology Workshop - ESTRO
Blog
May 29, 2025, 17:41
Amol Akhade: Can Perioperative Immunotherapy Change Outcomes in Resectable Gastric/GEJ Cancer?
Blog
May 29, 2025, 17:39
Patrick Ma: Looking Forward to ASCO 2025